查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年亚太地区微载体市场预测 - 区域分析 - 按产品、设备、应用和最终用户
市场调查报告书
商品编码
1494454

2030 年亚太地区微载体市场预测 - 区域分析 - 按产品、设备、应用和最终用户

Asia Pacific Microcarriers Market Forecast to 2030 - Regional Analysis - by Product, Equipment, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 96 Pages | 订单完成后即时交付

价格

亚太地区微载体市场预计将从2022年的3.6614亿美元成长到2030年的9.9123亿美元。

再生医学采用激增推动亚太微载体市场

再生医学的日益普及已成为推动微载体市场成长的重要驱动力。再生医学专注于修復、替换或再生受损的组织和器官，使其成为解决各种医疗状况的一个有前景的领域。微载体在细胞培养和扩增中发挥关键作用，这是再生医学的一个基本面向。

在再生医学中，细胞在移植前在体外培养，微载体为细胞附着、增殖和分化提供合适的环境。它们作为生物反应器中细胞生长的基质，促进大量细胞的高效生产。这对于需要大量活细胞和功能细胞的再生疗法尤其重要。

此外，微载体增强了细胞过程的可扩展性和成本效益，解决了再生医学从研究到临床应用转化的关键挑战。随着再生医学领域的不断发展，以及对干细胞疗法和组织工程的日益关注，对微载体的需求预计将不断升级，从而推动微载体市场的创新和扩张

亚太地区微载体市场概况

亚太地区的微载体市场分为中国、日本、印度、澳洲、韩国和亚太其他国家。亚太地区的一些国家在细胞和基因治疗研发方面投入大量资金。中国、印度和日本是该地区微载体市场成长的三个主要贡献者，市场成长可归因于企业对成本优化的日益重视、简化临床流程的快速努力、政府的支持政策、以及越来越多的临床试验。中华人民共和国政府致力于改善公共卫生，提供具有成本效益的公共卫生计划，扩大与健康相关的财政保障措施的覆盖范围，并投资于庞大的医疗服务网络。十三五规划预计，2020年生技产业对GDP的贡献率将超过4%，接近生命科学的10-20倍。中国有100多个由地方政府控制的生命科学园区正在运作，这些中心以税收优惠和补贴吸引企业。据报道，为了实现中国五年计画的目标，国家、省和地方政府已在生物科学领域投资超过1,000亿美元。 2003年，它成为第一个批准基因疗法的国家，从那时起，具有更高治疗潜力的细胞和基因疗法的开发在全球范围内加快了步伐。根据 2021 年《自然》杂誌发表的一项研究，全球超过 50% 的细胞治疗试验都在中国进行。该国目前有近 400 项正在进行的 CAR-T 试验，重点是血液学、肿瘤学和实体肿瘤。 2021年，国家药品监督管理局（NMPA）批准了復星凯特的Yescarta和JW Therapeutics的Relma-cel，中国的细胞治疗进入了新时代。

亚太地区微载体市场营收及 2030 年预测（百万美元）

亚太地区微载体市场区隔

亚太地区微载体市场分为产品、设备、应用、最终用户和国家。

根据产品，亚太微载体市场分为微载体珠和培养基和试剂。 2022 年，微载体珠细分市场在亚太微载体市场中占有更大份额。

在设备方面，亚太微载体市场分为生物反应器、培养皿等。 2022 年，生物反应器领域占据亚太微载体市场的最大份额。

根据应用，亚太微载体市场分为生物製药生产、细胞和基因治疗、组织工程和再生医学等。 2022年，生物製药生产领域在亚太微载体市场中占据最大份额。

根据最终用户，亚太微载体市场分为製药和生物技术公司、合约研究组织和合约製造组织以及学术和研究机构。 2022 年，製药和生物技术公司领域占据亚太微载体市场的最大份额。

根据国家/地区，亚太地区微载体市场分为中国、日本、印度、韩国、澳洲和亚太地区其他地区。 2022年，中国将主导亚太微载体市场。

Teijin Ltd、Bio-Rad Laboratories Inc、Sartorius AG、Danaher Corp、Corning Inc、Eppendorf SE、Asahi Kasei Corp 和 Polysciences Inc 是亚太微载体市场上的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区微载体市场 - 主要产业动态

  • 主要市场驱动因素：
    • 随着癌症和传染病发病率的上升，对细胞疗法的需求
    • 外包细胞和基因治疗製造越来越受欢迎
    • 再生医学的采用激增
  • 市场限制
    • 生物製剂和细胞疗法的高成本
  • 市场机会
    • 微载体製造商的策略性倡议和创新产品
  • 未来的趋势
    • 细胞和基因治疗製造服务的自动化
  • 影响分析

第 5 章：微载体市场 - 亚太市场分析

  • 微载体市场收入，2022 - 2030

第 6 章：亚太地区微载体市场 - 收入和 2030 年预测 - 按产品

  • 概述
  • 2022 年和 2030 年按产品分類的微载体市场收入份额 (%)
  • 微载体珠
  • 介质和试剂

第 7 章：亚太地区微载体市场 - 收入和 2030 年预测 - 按设备

  • 概述
  • 2022 年及 2030 年按设备分類的微载体市场收入份额 (%)
  • 生物反应器
  • 培养容器
  • 其他的

第 8 章：亚太地区微载体市场 - 2030 年收入与预测 - 按应用

  • 概述
  • 2022 年和 2030 年按应用分類的微载体市场收入份额 (%)
  • 生物製药生产
  • 细胞和基因治疗
  • 组织工程与再生医学
  • 其他的

第 9 章：亚太地区微载体市场收入和 2030 年预测 - 最终用户

  • 概述
  • 亚太地区最终用户微载体市场占有率 - 2022 年和 2030 年 (%)
  • 製药和生物技术公司
    • 概述
    • 製药和生物技术公司：微载体市场 - 收入和 2030 年预测
  • 合约研究组织和合约製造组织
    • 概述
    • 合约研究组织和合约製造组织：微载体市场 - 收入和 2028 年预测
  • 学术及研究机构
    • 概述
    • 学术和研究机构：微载体市场 - 收入和 2028 年预测

第 10 章：亚太地区微载体市场收入和 2030 年预测 - 国家分析

    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 韩国
      • 亚太地区其他地区

第 11 章：微载体市场-产业格局

  • 概述
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Teijin Ltd
  • Bio-Rad Laboratories Inc
  • Sartorius AG
  • Danaher Corp
  • Corning Inc
  • Eppendorf SE
  • Asahi Kasei Corp
  • Polysciences Inc

第 13 章：附录

Product Code: BMIRE00029978

The Asia Pacific microcarriers market is expected to grow from US$ 366.14 million in 2022 to US$ 991.23 million by 2030. It is estimated to record a CAGR of 13.3% from 2022 to 2030.

Surge in Adoption of Regenerative Medicine Fuels Asia Pacific Microcarriers Market

The rising adoption of regenerative medicine has emerged as a significant driver propelling the growth of the microcarriers market. Regenerative medicine focuses on repairing, replacing, or regenerating damaged tissues and organs, making it a promising field for addressing various medical conditions. Microcarriers play a pivotal role in the cultivation and expansion of cells, a fundamental aspect of regenerative medicine.

In regenerative medicine, cells are cultured outside the body before being transplanted, and microcarriers provide a suitable environment for cell attachment, proliferation, and differentiation. They serve as a substrate for cell growth in bioreactors, facilitating the efficient production of large quantities of cells. This is particularly crucial for regenerative therapies, where a substantial number of viable and functional cells are needed.

Moreover, microcarriers enhance the scalability and cost-effectiveness of cell processes, addressing key challenges in the translation of regenerative medicine from research to clinical applications. As the regenerative medicine field continues to advance, with an increasing focus on stem cell therapies and tissue engineering, the demand for microcarriers is expected to escalate, driving innovation and expansion within the microcarriers market

Asia Pacific Microcarriers Market Overview

The microcarrier market in Asia Pacific is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific countries. Several countries in Asia Pacific invest significantly in cell and gene therapy R&D. China, India, and Japan are the three major contributors to the growth of the microcarriers market in this region, and the market growth can be attributed to the growing emphasis of businesses on cost optimization, burgeoning efforts to streamline clinical processes, supportive government policies, and increasing number of clinical trials. The government of the People's Republic of China is focused on improving public health, providing cost-effective public health programs, expanding the coverage of health-related financial protection measures, and investing in a vast healthcare delivery network. The 13th Chinese plan expected a more than 4% contribution of the biotechnology industry to the GDP in 2020, which would be nearly 10-20 life-science parities. More than 100 life-science parks controlled by local governments are functional across China, and these centers entice enterprises with tax advantages and subsidies. State, provincial, and local governments are reported to have already invested more than US$ 100 billion in the biosciences sector to meet the goals of the five-year plan of China. In 2003, it became the first country to approve a gene therapy, and since then, the development of cell and gene therapies with elevated therapeutic potential has picked pace worldwide. According to a study published in Nature in 2021, China is home to more than 50% of all cell therapy trials across the world. The country currently has nearly 400 ongoing CAR-T trials centered on hematology, and oncology and solid tumors. In 2021, the National Medical Products Administration (NMPA) approved Fosun Kite's Yescarta and JW Therapeutics' Relma-cel, with which cell therapies in China entered a new era.

Asia Pacific Microcarriers Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Microcarriers Market Segmentation

The Asia Pacific microcarriers market is segmented into product, equipment, application, end user, and country.

Based on product, the Asia Pacific microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held a larger share of the Asia Pacific microcarriers market in 2022.

In terms of equipment, the Asia Pacific microcarriers market is segmented into bioreactors, culture vessels, and others. The bioreactors segment held the largest share of the Asia Pacific microcarriers market in 2022.

Based on application, the Asia Pacific microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production segment held the largest share of the Asia Pacific microcarriers market in 2022. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.

Based on end user, the Asia Pacific microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held the largest share of the Asia Pacific microcarriers market in 2022.

Based on country, the Asia Pacific microcarriers market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific microcarriers market in 2022.

Teijin Ltd, Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Asahi Kasei Corp, and Polysciences Inc are some of the leading companies operating in the Asia Pacific microcarriers market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Microcarriers Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
    • 4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
    • 4.1.3 Surge in Adoption of Regenerative Medicine
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Biologics and Cell-based Therapies
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
  • 4.4 Future Trends
    • 4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
  • 4.5 Impact Analysis

5. Microcarriers Market - Asia Pacific Market Analysis

  • 5.1 Microcarriers Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Microcarriers Market - Revenue and Forecast to 2030 - by Product

  • 6.1 Overview
  • 6.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 Microcarrier Beads
    • 6.3.1 Overview
    • 6.3.2 Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Media and Reagents
    • 6.4.1 Overview
    • 6.4.2 Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Microcarriers Market - Revenue and Forecast to 2030 - by Equipment

  • 7.1 Overview
  • 7.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • 7.3 Bioreactors
    • 7.3.1 Overview
    • 7.3.2 Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Culture Vessels
    • 7.4.1 Overview
    • 7.4.2 Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Microcarriers Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Biopharmaceutical Production
    • 8.3.1 Overview
    • 8.3.2 Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.3 Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.4 Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Cell and Gene Therapy
    • 8.4.1 Overview
    • 8.4.2 Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Tissue Engineering and Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Microcarriers Market Revenue and Forecasts To 2030 - End User

  • 9.1 Overview
  • 9.2 Asia Pacific Microcarriers Market Share by End User - 2022 & 2030 (%)
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Contract Research Organizations and Contract Manufacturing Organizations
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Microcarriers Market Revenue and Forecasts to 2030 - Country Analysis

  • 10.1 Asia Pacific Microcarriers Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific: Microcarriers Market, by Country
      • 10.1.2.1 China
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 China: Microcarriers Market Revenue and Forecast to 2030 (CHINA$ Mn)
        • 10.1.2.1.3 China: Microcarriers Market, by Product
        • 10.1.2.1.4 China: Microcarriers Market, by Equipment
        • 10.1.2.1.5 China: Microcarriers Market, by Application
        • 10.1.2.1.5.1 China: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.1.6 China: Microcarriers Market, by End User
      • 10.1.2.2 Japan
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 Japan: Microcarriers Market, by Product
        • 10.1.2.2.4 Japan: Microcarriers Market, by Equipment
        • 10.1.2.2.5 Japan: Microcarriers Market, by Application
        • 10.1.2.2.5.1 Japan: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.2.6 Japan: Microcarriers Market, by End User
      • 10.1.2.3 India
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 India: Microcarriers Market, by Product
        • 10.1.2.3.4 India: Microcarriers Market, by Equipment
        • 10.1.2.3.5 India: Microcarriers Market, by Application
        • 10.1.2.3.5.1 India: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.3.6 India: Microcarriers Market, by End User
      • 10.1.2.4 Australia
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Australia: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
        • 10.1.2.4.3 Australia: Microcarriers Market, by Product
        • 10.1.2.4.4 Australia: Microcarriers Market, by Equipment
        • 10.1.2.4.5 Australia: Microcarriers Market, by Application
        • 10.1.2.4.5.1 Australia: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.4.6 Australia: Microcarriers Market, by End User
      • 10.1.2.5 South Korea
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.3 South Korea: Microcarriers Market, by Product
        • 10.1.2.5.4 South Korea: Microcarriers Market, by Equipment
        • 10.1.2.5.5 South Korea: Microcarriers Market, by Application
        • 10.1.2.5.5.1 South Korea: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.5.6 South Korea: Microcarriers Market, by End User
      • 10.1.2.6 Rest of Asia Pacific
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.3 Rest of Asia Pacific: Microcarriers Market, by Product
        • 10.1.2.6.4 Rest of Asia Pacific: Microcarriers Market, by Equipment
        • 10.1.2.6.5 Rest of Asia Pacific: Microcarriers Market, by Application
        • 10.1.2.6.5.1 Rest of Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.6.6 Rest of Asia Pacific: Microcarriers Market, by End User

11. Microcarriers Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Growth Strategies
    • 11.2.1 Overview
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Teijin Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Bio-Rad Laboratories Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Sartorius AG
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Danaher Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Corning Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Eppendorf SE
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Asahi Kasei Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Polysciences Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Microcarriers Market Segmentation
  • Table 2. China Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 3. China Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 4. China Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 5. China Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 6. China: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 7. Japan Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 8. Japan Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 9. Japan Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 10. Japan Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 11. Japan: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 12. India Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 13. India Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 14. India Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 15. India Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 16. India: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 17. Australia Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 18. Australia Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 19. Australia Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 20. Australia Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 21. Australia: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 22. South Korea Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 23. South Korea Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 24. South Korea Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 25. South Korea Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 26. South Korea: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 27. Rest of Asia Pacific Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 28. Rest of Asia Pacific Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 29. Rest of Asia Pacific Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 30. Rest of Asia Pacific Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 31. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 32. Recent Organic Growth Strategies in Microcarriers Market
  • Table 33. Recent Inorganic Growth Strategies in the Microcarriers Market
  • Table 34. Glossary of Terms

List Of Figures

  • Figure 1. Microcarriers Market Segmentation, By Country
  • Figure 2. Key Insights
  • Figure 3. Microcarriers Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints for Microcarriers Market
  • Figure 5. Microcarriers Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 7. Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • Figure 10. Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 14. Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Asia Pacific Microcarriers Market Share by End User - 2022 & 2030 (%)
  • Figure 21. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 22. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 23. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 24. Microcarriers Market, 2022 (US$Mn)
  • Figure 25. Asia Pacific: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 26. China: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Australia: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)